<unk>  is a combination of a  human immunodeficiency virus protease inhibitor and a CYP3A inhibitor that is FDA approved for the treatment of HIV-1 infection in combination with other antiretroviral agents.   Common adverse reactions include abnormal bilirubin levels, jaundice, and scleral icterus.
Atazanavir and cobicistat
Ombitasvir, paritaprevir, and ritonavir
Darunavir ethanolate and cobicistat
Elbasvir / grazoprevir
Dolutegravir / rilpivirine
Sofosbuvir / velpatasvir
Glecaprevir / pibrentasvir
Lopinavir ritonavir